X0508 4 2024-03-01 false 0001524472 Xylem Inc. XYL 0001813828 Cerwinka Franz C/O XYLEM INC. 301 WATER STREET SE WASHINGTON DC 20003 false true false false SVP & Pres, AWS & Bus Trnsform false Common Stock 2024-03-01 4 A false 1203.00 127.94 A 12953.00 D Common Stock 2024-03-01 4 A false 1956.00 127.94 A 14909.00 D Common Stock 2024-03-01 4 F false 1509.00 127.94 D 13400.00 D Common Stock 2024-03-01 4 F false 730.00 127.94 D 12670.00 D Common Stock 2024-03-01 4 A false 1563.00 127.94 A 14233.00 D Common Stock 2024-03-01 4 S false 1341.00 127.44 D 12892.00 D Stock Options (Right to buy) 127.94 2024-03-01 4 A false 5288.00 127.94 A 2034-03-01 Common Stock 5288.00 5288.00 D Reflects the acquisition of 1,203 shares of common stock upon vesting of performance-based restricted stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Reflects the acquisition of 1,956 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (193), March 1, 2022 (246), and March 1, 2023 (291) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a price of $127.44. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. /s/ Seaneen Cline, by power of attorney for Franz Cerwinka 2024-03-05